AULIN SHERRY
SEC CIK 1862144 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | CFO | 11.5K | — | $1.38M | 6 | 2022-09-02 | 2024-12-18 |
Most active insiders at XENE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORTIMER IAN | Pres, CEO, INTERIM CFO, Dir | — | $21.30M |
| 2 | KENNEY CHRISTOPHER JOHN | Chief Medical Off | — | $670.3K |
| 3 | GANNON STEVEN | Dir | — | $640.6K |
| 4 | DiFabio Andrea | CLO | — | $230.8K |
| 5 | PATOU GARY | Dir | — | $70.3K |
| 6 | Cannon Gillian | Dir | — | $63.2K |
| 7 | GAROFALO ELIZABETH A. | Dir | — | — |
| 8 | Gover Justin D. | Dir | — | — |
| 9 | Svoronos Dawn | Dir | — | — |
| 10 | Machado Patrick | Dir | — | — |
AULIN SHERRY made no open-market trades at XENE in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-19 | 2024-12-18 | XENE | Xenon Pharmaceuticals Inc. | AULIN SHERRY | CFO | F - Tax | $41.28 | -6,625 | 11.5K | -37% | -$273.5K |
| DM | 2024-12-19 | 2024-12-18 | XENE | Xenon Pharmaceuticals Inc. | AULIN SHERRY | CFO | M - OptEx | $10.79 | +25.3K | 9,334 | New | +$273.4K |
| DM | 2024-12-19 | 2024-12-18 | XENE | Xenon Pharmaceuticals Inc. | AULIN SHERRY | CFO | S - Sale+OE | $41.21 | -18.7K | 0 | -100% | -$770.9K |
| DM | 2022-09-07 | 2022-09-02 | XENE | Xenon Pharmaceuticals Inc. | AULIN SHERRY | CFO | M - OptEx | $6.97 | +18.6K | 9,032 | New | +$130.1K |
| D | 2022-09-07 | 2022-09-02 | XENE | Xenon Pharmaceuticals Inc. | AULIN SHERRY | CFO | F - Tax | $39.53 | -3,293 | 15.4K | -18% | -$130.2K |
| D | 2022-09-07 | 2022-09-02 | XENE | Xenon Pharmaceuticals Inc. | AULIN SHERRY | CFO | S - Sale+OE | $39.57 | -15.4K | 0 | -100% | -$607.6K |
Purchase Sale Sale after option exercise All abbreviations